Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial

Robert D. McBane, Charles L. Loprinzi, Aneel Ashrani, Charles J. Lenz, Damon Houghton, Tyler Zemla, Jennifer G. Le-Rademacher, Waldemar E. Wysokinski

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'Extending venous thromboembolism secondary prevention with apixaban in cancer patients: The EVE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences